The amyloid (A), tau (T), and neurodegeneration (N) (known as ATN) biomarkers are increasingly promising for predicting Alzheimer’s Disease risk in older populations.6 This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.